The association of PTPIC deficiency with the multiplicity of lymphoid cell abnormalities manifested by motheaten (me) and viable motheaten (me 9 mice suggests a pivotal role for this tyrosine phosphatase in the regulation of lymphocyte differentiation and function. To delineate the relevance of PTP1C to T cell physiology, we have examined me and me ~ T cells with regards to their capacity to transduce activating signals through the T cell antigen receptor (TCR). Although thymocyte maturation appeared normal in the mutant mice, both thymocytes and peripheral T cells from these animals exhibited proliferative responses to TCR stimulation that were markedly increased relative to those elicited in normal cells. Compared to normal thymocytes, PTP1C-deficient thymocytes also showed increased constitutive tyrosine phosphorylation of the TCR complex and enhanced and prolonged TCR-induced tyrosine phosphorylation of the TCR-~ and CD3-e, as well as a number of cytosolic proteins, most notably a 38-kD phosphoprotein found to associate with the Grb2 adaptor SH2 domain in activated thymocytes. These latter phosphoproteins also associated with the Vav guanine nucleotide exchange factor upon TCR ligation, and were dephosphorylated by recombinant PTP1C in vitro. In conjunction with the finding of PTP1C-TCR association in unstimulated normal thymocytes, these results reveal the capacity of PTP1C to interact with and likely dephosphorylate resting and activated TCR complex components, as well as more distal signaling effectors that are normally recruited to the Vav and Grb2 SH2 domains after TCR stimulation. These data therefore strongly implicate PTP1C in the downregnlation of TCR signaling capacity and, taken together with the aberrant prolongation of TCR-induced, mitogen-associated kinase (MAPK) activation observed in PTP1C-deficient thymocytes, these findings suggest that the inhibitory influence of PTP1C on TCR signal relay is realized through its effects on both the TCR complex and downstream signaling elements that couple the activated antigen receptor to the Ras/MAPK response pathway.
Summary
The association of PTPIC deficiency with the multiplicity of lymphoid cell abnormalities manifested by motheaten (me) and viable motheaten (me 9 mice suggests a pivotal role for this tyrosine phosphatase in the regulation of lymphocyte differentiation and function. To delineate the relevance of PTP1C to T cell physiology, we have examined me and me ~ T cells with regards to their capacity to transduce activating signals through the T cell antigen receptor (TCR). Although thymocyte maturation appeared normal in the mutant mice, both thymocytes and peripheral T cells from these animals exhibited proliferative responses to TCR stimulation that were markedly increased relative to those elicited in normal cells. Compared to normal thymocytes, PTP1C-deficient thymocytes also showed increased constitutive tyrosine phosphorylation of the TCR complex and enhanced and prolonged TCR-induced tyrosine phosphorylation of the TCR-~ and CD3-e, as well as a number of cytosolic proteins, most notably a 38-kD phosphoprotein found to associate with the Grb2 adaptor SH2 domain in activated thymocytes. These latter phosphoproteins also associated with the Vav guanine nucleotide exchange factor upon TCR ligation, and were dephosphorylated by recombinant PTP1C in vitro. In conjunction with the finding of PTP1C-TCR association in unstimulated normal thymocytes, these results reveal the capacity of PTP1C to interact with and likely dephosphorylate resting and activated TCR complex components, as well as more distal signaling effectors that are normally recruited to the Vav and Grb2 SH2 domains after TCR stimulation. These data therefore strongly implicate PTP1C in the downregnlation of TCR signaling capacity and, taken together with the aberrant prolongation of TCR-induced, mitogen-associated kinase (MAPK) activation observed in PTP1C-deficient thymocytes, these findings suggest that the inhibitory influence of PTP1C on TCR signal relay is realized through its effects on both the TCR complex and downstream signaling elements that couple the activated antigen receptor to the Ras/MAPK response pathway.
T he intracellular events linking TCR engagement to a physiologic response involve a multiplicity of molecular interactions, the specificity and sequelae of which depend on the cell's developmental stage and exposure to costimulatory signals. Although the precise amalgam of molecular events that translate TCR engagement to specific types of cell behavior remain unclear, a wealth of information has accrued with respect to the general molecular strategies used to couple the stimulated TCR to the nucleus. As for other growth receptors, the downstream propagation of activation signals from the TCR is known to be critically dependent on tyrosine phosphorylation, both TCR components and numerous cytosolic signaling effectors becoming rapidly phosphorylated after TCR stimulation (1) . In contrast to many growth factors, however, the signaling elements within the TCR complex lack intrinsic enzymatic activity, and their tyrosine phosphorylation is thus achieved through interactions with nonreceptor protein tyrosine kinases (PTKs) ~, most notably ZAP-70, syk, and the srcrelated ick and fyn proteins (2, 3) . The effects of these PTKs on TCR signaling capacity primarily reflects their phosphorylation oftyrosine residues mapping within highly conserved domains (tyrosine-based activation motifs) of the TCR-CD3-e, ~ and ~ subunits with the consequent generation of high affinity binding sites for the recruitment of SH2 domain-containing effectors into the activation path-way (4, 5) . One such signaling effector is the ZAP-70 PTK, which upon TCR ligation, binds via its SH2 domains to tyrosine-phosphorylated TCR and manifests a marked increase in catalytic activity thought to be responsible for the phosphorylation and activation ofphospholipase C (PLC) yl and consequent induction of the phosphoinositide second-messenger pathway (6) (7) (8) . Along similar lines, PTK-mediated tyrosine phosphorylation of TCP, subunits also results in recruitment of Grb2 and possibly other adaptor proteins, and these in turn serve to link the activated receptor to guanine nucleotide exchange factors (GEFs), such as mSos, and thus to the activation of Ras and downstream mitogen-activated protein (MAP) kinases (9, 10) . While TCR signaling capacity clearly reflects a host of other molecular interactions, these examples illustrate the pivotal role for PTK-induced phosphorylation in the coupling of TCR engagement to a cell response.
In contrast to the extensive data that is available concerning PTK involvement in TCR-driven signaling events, much less is known with respect to the contribution of protein tyrosine phosphatases (PTPs) to the modulation of antigen receptor function. On the basis of considerable biochemical and genetic data, the single PTP that has been widely studied in relation to T cell signaling, CD45, appears to exert a primarily positive influence on the TCR signaling capacity activity of this enzyme, apparently promoting T cell development and activation (11) (12) (13) . By contrast, the observed capacity of phosphatase inhibitors to enhance or even induce intracellular molecular events normally elicited by TClq. ligation (14) suggests that at least some PTPs act in the downregulation of TCR.-evoked signaling events. Thus, by providing the biochemical means to counterbalance PTK effects and terminate receptor-initiated signal transmission, PTPs potentially exert a key inhibitory influence on T cell signaling circuitry.
Among the PTPs identified to date, the cytosolic enzyme PTP1C (SHP/HCP/SHPTP1) represents a signaling effector that is particularly likely to be involved in the negative regulation of TCR signaling capacity. This SH2 domain-containing enzyme has, for example, been shown to not only physically associate with the antigen receptor on B cells (BCR), but to downregulate BCR-transduced signals evoking either the activation of mature B cells or the deletion/negative selection of autoreactive precursor B cells (15, 16) . PTP1C interactions with the CD22 and FcyRIIB receptors on B cells also appear to culminate in the downregulation of BCP,.-triggered activation signals (17, 18) . These findings, together with recent data revealing a negative regulatory influence of PTP1C on the signaling functions of the erythropoietin and IL-3 receptors (19, 20) , suggest that PTP1C may also exert inhibitory effects on the signaling cascades elicited by TCR engagement. To address this possibility, we have examined TCR signaling capacity in thymocytes from motheaten (me) and viable motheaten (me v) mice, animals in which PTP1C gene mutations result in the absence of catalytically active enzyme (21, 22). While overt defects in thymocyte maturation were not detected in the mutant mice, the induction of proliferation, protein tyrosine phosphorylation, and MAP kinase activity after TCt/. stimulation was markedly increased in me and me ~ thymocytes relative to cells from congenic wild-type mice. Among the phosphoproteins showing increased levels and duration of tyrosine phosphorylation in the TCRstimulated mutant cells were a number of species that associate with PTP1C and/or the Vav SH2 domain, and that are subject to PTP1C tyrosine dephosphorylation in vitro. These latter proteins were found to include several components of the TCR complex, as well as a 38-kD species (pp38) that also associates strongly with the SH2 domain of the Grb2 adaptor protein after TCP, ligation. Together, these findings indicate that PTPIC is involved in the downregulation of TCR-initiated signal transduction pathways, and suggest that PTP1C subserves this inhibitory role through participation in a nmltimeric signaling complex comprised of PTP1C, Vav, Grb2, and various phosphoproteins such as pp38 and phosphorylated TCR subunits, which appear to represent PTP1C substrates. These findings therefore reveal the negative influence of PTP 1C on T cell signaling to be realized through PTP1C effects on both the TCR complex and more downstream signaling effectots that couple the TCP,. to Ras/MAP kinase activation.
Materials and Methods
Mice. Mice for this work were obtained by mating C3HeBFeJ me/+ and +/+ and C57BL/6J me'/+ and +/+ breeding pairs derived from stock maintained at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital (Toronto, Ontario). All mice used in this study were 2-3 wk old.
Reagents. Antibodies used for these studies include FITCconjugated anti-CD4, PE-conjugated anti-CD8, and biotin-conjugated monoclonal hamster anti-mouse TCR (13 chain) antibodies (Pharmigen, San Diego, CA); a monoclonal rat anti-mouse CD3 antibody provided by Dr. G. Mills (M.D. Anderson Cancer Center, Houston, TX); a monoclonal rat anti-mouse CD5 antibody (Pharmigen); rabbit polyclonal anti-Vav, anti-Grb2, and anti-EP,.K2(MAPK) antibodies (Santa Cruz Laboratories, Santa Cruz, CA); 4G10 monoclonal anti-phosphotyrosine antibody (Upstate Biotechnology Inc., Lake Placid, NY); rabbit polyclonal PTPlC SH2 domain antibody produced in our lab (2l); a rabbit polyclonal anti-mouse TCR-~ provided by Dr. U Samelson (NIH, Bethesda, MD); monoclonal anti-mouse CD3-~ provided by Dr. A. Singer (NIH, Bethesda, MD); and mouse lgG (Sigma Chemical Co., St. Louis, MO). The glutathione S-transferase (GST) fusion proteins used in this study were derived by subcloning the following cDNA or PCR-amp]ified fragments into pGEX2T: the full-length murine PTP1C cl)NA (PTP-1C/ GST), a full-length murine PTP1C cDNA containing a Cys453-+Ser mutation known to abrogate catalytic activity, provided by Dr. W. Muller, (McMaster University, Hamilton, Ontario) (C/SPTP1C/GST), and the Vav SH2 domain (amino acids 663-776) alone (Vav SH2/GST) and the Grb2 SH2 domain (amino acids 60--158) alone (Grb2 SH2/GST), provided by l)r. M. P,.ozakis-Adcock (Toronto, Ontario) (23). These GST expression plasmids were transfected into Esdlerichia coil JM 101, and the fusion proteins were purified from bacterial lysates after isopropyl 13-D-thiogalactopyranoside induction. OVA was obtained from U.S. Biochemical Corp. (Cleveland, OH) and Con A, PMA, and all chemicals for immunoblotting/immunoprecipitation analyses were purchased from Sigma Chemical Co.
Cells and Cell Lines. Single-cell suspensions were prepared from me, me v, and wild-type congenic (+/+) lymph nodes and thymus, subjected to erythrocyte lysis by 2-rain incubation in 0.8% ammonium chloride and the viability was determined by staining in 0.4% trypan blue (Sigma Chemical Co.). The murine EL4 thymoma (TIB 39; American Type Culture Collection, ILockville, MD) was maintained at 37~ in complete DMEM medium (GIBCO BRL, Gaithersburg, MD) containing 10% FCS (GIBCO BILL), 50 Izm 2-ME, 2 mm L-glutamine, and nonessential amino acids. Cells were harvested in log growth phase.
Fluorescence Staining (FACS) | Single-cell suspensions prepared from me, me ~, and wild-type congenic thymus were assessed for CD4, CD8, and TCIL expression by immunofluorescent analysis, as described previously (24) . Briefly, erythrocyte-depleted thymic single-cell suspensions (106 cells) were incubated for 30 rain at 4~ with anti-CD4-FITC, anti-CD8-PE, and biotinylated anti-TCR antibodies. Cells were then washed and incubated for a further 30 rain at 4~ with Tricolor Avidin (Caltag Laboratories, San Francisco, CA), and were then washed and resuspended in staining solution. All samples were then examined by fluorescence cytometry using a FACScan | cell analyzer (Becton Dickinson & Co., Mountain View, CA).
Proliferation Assays. Singe-cell suspensions of thymocytes harvested from me, me", and wild-type littermates were cultured in 96-well flat-bottom microtiter plates (5 • 105 cells/100 I.zl per well) in (x-MEM (GIBCO BILL) containing 10% heat-inactivated FCS, 50 I~M 2-ME, and penicillin/streptomycin. For proliferation studies, cells were cultured directly with either 2.2 I~g Con A or 50 ng/ml PMA plus ionomycin (1 IxM), or in the presence of 25 U/ml IL-2 (Sigma) in anti-CD3 antibody-coated culture plates prepared by overnight incubation of the plates at 4~ with anti-CD3 antibody dissolved in 0.05 M Tris-HC1, pH 9.2. Cells were cultured for 48 h at 37~ 5% CO2, and pulsed with [3H]thymidine (1 I~Ci/well; Amersham International, Amersham, UK) 6 h before terminating incubation, and incorporated radioactivity was measured using an automated 13 liquid scintillation counter. For OVA proliferation assays, groups of me v mice and normal littermates were treated by footpad injection of 50 or 100 p~g, respectively, OVA in CFA (GIBCO BILL), or CFA alone, as previously described (24) . Animals were killed 7 d after immunization, and their popliteal, inguinal, and paraaortal lymph nodes were harvested and used to prepare single-cell suspensions. To reduce effects of differences between me" and normal accessory cells, cells obtained from two OVA-primed animals from the same group (i.e., me" or normal) were pooled and mixed with equal numbers of cells obtained from the CFA-only-treated mice of the other group. Cells were then cultured (5 • 105 cells/well) for 72 h in a-MEM medium (as described above) in the presence or absence of varying amounts of OVA (ranging from 300 ng/ml to 3 mg/ml), and radiolabeled thymidine incorporation during the last 6 h of culture was evaluated as described above.
Cell Stimulation and Lysis. For analysis of protein wrosine phosphorylation and binding studies (see below), 2-3 • 107 thymocytes or 3 • 107 EL4 cells were resuspended in, respectively, 50 or 100 I~1 PBS, incubated for 30 rain at 4~ in the presence or absence of 2.5 Ixg biotin-conjugated anti-mouse TCIL antibody, and after the removal of unbound antibody, the cells were resuspended in 40 txl PBS and incubated at 37~ for varying periods of time with 100 I, Lg/ml avidin. Alternatively, 3 • 107 thymocytes or EL4 cells were resuspended in 100 Izl PBS and then incubated for 2 rain at 37~ with pervanadate (1 mM Na3VOa plus 300 m/Vl H202). After antibody or pervanadate stimulation, cells were pelleted by an 0.5-min centrifugation and then lysed by resuspension in 400 txl cold lysis buffer (150 mM NaC1, 50 Tris-HC1, pH 8, 2 rnM EDTA, 50 m/Vl NaF, 1 mM PMSF, 1 mM sodium orthovanadate, and 0.05% NAN3) containing either 1% NP-40 or 0.5% Triton X-100 as detergents. After a 15-rain incubation in lysis buffer, nuclei and unlysed cells were removed by centrifugation at 4~ for 10 min at 14,000 g, and 106 cell equivalents were then resuspended in SDS loading buffer and used as the source of protein lysates (see below).
lmmunoprecipitation and Immunoblotting. Lysates were precleared before immunoprecipitation by incubating 1 mg lysate protein with protein A-Sepharose (Pharmacia, Baie d'Urf~, PQ) (40 txl lysate in 1-ml volume beads) for 1 h at 4~ and for an additional hour with 40 I~1 beads and 5 ILl rabbit preimmune serum. Lysates were then incubated for 3 h at 4~ with 5 Ix] specific antibody or rabbit preimmune serum and 25 p,1 packed protein A-Sepharose beads, and the immune complexes were then collected by centrifugation, washed four times in lysis buffer, and resuspended in SDS sample buffer. Alternatively, for reprecipitation studies, the immune complexes were collected by centrifugation, resuspended in 200 I-tl lysis buffer with 0.5% SDS, and then boiled for 5 rain. The resolubilized proteins were then further diluted by resuspension in an additional 800 Ixl oflysis buffer and subjected to a second 3-h incubation at 4~ with 5 I.L1 antibody and 25 Ixl protein A-Sepharose beads followed by centrifugation, washing in lysis butter, and resuspension is SDS. The samples were boiled for 5 rain, electrophoresed through 10 or 15% SDS-polyacrylamide, transferred to nitrocellulose (Schleicher & Schuller Inc., Keene, NH), and incubated at 4~ for at least 1 h in TBST solution (150 mM NaC1, 10 mM Tris-HC1, pH 7.4, 0.05% Tween 20) plus 3% gelatin. Filters were then incubated for 2 h at room temperature with primary antibodies (1/5,000 dilution) in TBST followed by the addition of goat anti-mouse antiserum labeled with peroxidase (Amersham) and horseradish peroxidase-conjugate (BioRad Laboratories, Hercules, CA). Immune complexes were detected using an enhanced chemiluminescence system (Amersham).
In Vitro Binding Assays. Protein binding to various GST-SH2 domain fusion proteins was examined by incubating total cell lysates (1 rag) for 1 h at 4~ with glutathione-Sepharose beads alone, and then for 3 h at 4~ with 5 txg glutathione-Sepharosebound fusion protein. After four washes in lysis buffer, the precipitated complexes were resuspended in sample buffer, boiled, and analyzed by SDS-PAGE, and immunoblotted with selected antibodies as described above.
Assay of Phosphatase Activity. To measure PTP1C-induced dephosphorylation of Vav-associated proteins, Vav SH2-bound proteins prepared from 5 X 107 anti-TCiL antibody-stimulated wild-type thymocytes were washed three times in lysis buffer and twice in phosphatase buffer (62 m/vl Hepes, pH 7, 6.25 m/Vl EDTA), and then incubated at 37~ for varying periods of time in 25 ILl phosphatase buffer containing 12.5 mM DTT and either 1 I~g or no (control) GST full-length PTP1C fusion protein. Reactions were terminated by the addition of 6 I, zl 5 • SDS loading buffer, and the samples were then subjected to immunoblotting analysis with antiphosphotyrosine antibody.
Assay of MAP Kinase Activity. Anti-ERK2 immunoprecipitates were prepared from 107 anti-TCR antibody-or PMA (25 nM)-stimulated wild-type thymocytes at varying intervals after cell stim-ulation, and the immunoprecipitated proteins were washed and resuspended in 25 Ixl reaction buffer (30 m M Tris-HC1, pH 8.0, 20 mM Mg CI2, 2 m M MnC12 containing 5 Ixg myelin basic protein (MBP; Upstate Biotechnology Inc.) and 10 IxCi [.y32_p] ATP (DuPont/New England Nuclear). After a 15-min incubation at 30~ reactions were terminated by the addition of 6 Ixl 5• loading buffer, and the samples were then boiled, electrophoresed through 15% polyacrylamide gels, and transferred to nitrocellulose. The phosphorylated MBP bands were either visualized by phosphoimaging or stained with Pounceau S, excised from the filters, and ~/32p incorporation was evaluated by liquid scintillation counting.
Results

TCR-elicited Proliferation Is Enhanced in me and me' T Cells.
R e c e n t data implicating P T P 1 C in the modulation o f n u m e r o u s h e m o p o i e t i c cell growth factor receptors and indicating the substantial expression o f this phosphatase in b o t h thymocytes and mature peripheral T cells have revealed a likely role for P T P I C in the regulation o f T C I < signaling (15, (19) (20) (21) . T o begin elucidating P T P 1 C ' s influence on the o n t o g e n y and activation o f T cells, thymic cells isolated from P T P l C -d e f i c i e n t motheaten (me) and viable m o t h e a t e n (me ~) mice were compared with normal thymocytes with respect to the surface expression o f C D 4 , C D 8 , and T C P , , as well as proliferative responses to T C Rdependent mitogenic stimuli. As shown in Fig. 1 , results o f three-color flow cytometry revealed no differences between me" and control thymocytes with respect to the numbers o f C D 4 , C D 8 , double-positive cells, and C D 4 and C D 8 single-positive cells and T C R expression. Thus, it appears that T cell differentiation can proceed nomlally in the absence o f P T P 1 C , a conclusion consistent with previous data linking the progressive thymic involution that occurs in me and me" mice primarily to the pathogenic effects of infiltrating myelomonocytic ceils rather than to intrinsic T cell defects per se (25) . In contrast to differentiation, however, thymocyte proliferative responses to T C R stimulation, as evaluated by [3H]thymidine incorporation, differed markedly between the mutant mice and wild-type controls. Me" thymocytes, for example, in which PTP1C catalytic activity is present, but at very low levels, exhibited maximal proliferative responses to both Con A and anti-CD3 antibody/IL-2 stimulation that were much greater in magnitude than those observed in similarly treated thymic cells from normal littermates (Fig. 1 /3 ). Hyperresponsiveness to T C R stimulation was even more pronounced in thymocytes from me mice, which lack any PTP1C activity ( Fig. 1 B) , and was also revealed by the apparent capacity of both me and me ~ thymic cells to proliferate in response to normally submitogenic concentrations of Con A (data not shown). By contrast, both the magnitude and kinetics of the proliferative responses to several TCR-independent stimuli, including IL-2 alone and PMA/ionomycin, were essentially the same in the mutant and wild-type thymocytes (data not shown). Together, these data reveal a defect in the transduction of T C R -e v o k e d proliferation signals in me and me" thymic cells and suggest that P T P I C effects on TCR-driven mitogenesis may be similar to those previously described in relation to the B C R (15) .
To determine whether PTP1C also influences antigen receptor function in mature T cells, lymphocytes obtained from lymph nodes of OVA-primed me". and wild-type congenic mice were compared with respect to their in vitro proliferative responses to O V A stimulation. Since these studies were performed using crude lymph node suspensions, the potential influence of contaminating antigen-presenting nonlymphoid cells was addressed by culturing the 843 Pani et al.
OVA-primed me v cells with CFA-primed cells from normal congenic mice in a 1:1 ratio. As shown in Fig. 1 C, the results of this analysis revealed the T cell proliferative responses to varying doses of antigen stimulation to be again substantially increased in me v compared to control lymphocytes. While this result might reflect the capacity of a more permissive microenvironment to increase the sensitivity of the me" cells to in vivo priming, this possibility seems unlikely in view of considerable data imbuing the me and me v mutations with a predominantly inhibitory effect on lymphoid cell growth and function (26, 27) . Instead, these data are more consistent with a role for PTP1C in regulating TCR-elicited mitogenesis in both mature T cells and thymocytes and suggest that the effects of P T P I C on T C R signaling are largely inhibitory.
T C R Complex Components Associate with P T P 1 C in Resting and Activated Thgmocytes, and Are Hyperphosphorylated in the Context of P T P I C Deficiency.
To elucidate the molecular basis for PTP1C influence on TCR-initiated T cell proliferation, me" and normal thymocytes were next compared with respect to their profiles of protein tyrosine phosphorylation after T C R ligation. As demonstrated by antiphosphotyrosine immunoblotting analysis, anti-TCR antibody treatment resulted in the rapid tyrosine phosphorylation of a number of protein species in both the normal and me" cells (Fig. 2 A) . However, in contrast to the wild-type cells, in which tyrosine phosphorylation levels peaked --~1 rain after T C R ligation, me v thymocytes showed more sustained increases in tyrosine phosphorylation, with at least four phosphoproteins (75-, 70-, 38-, and 26-kD species) remaining relatively hyperphosphorylated at 5 and even 30 min after cell stimulation. Among these latter proteins, the phosphorylation of the 75-and 38-kD species also appeared relatively increased in unstimulated me" compared to normal thymocytes (Fig. 2 A) . These data, together with our detection o f similar changes in tyrosine dephosphorylation kinetics in TCP..-stimulated me thymocytes (data not shown), suggest that P T P l C effects on T C R -i n d u c e d proliferation are realized, at least in part, at the earliest stages of signal transduction, and might include modulation o f the T C I L complex tyrosine phosphorylation status. T o begin addressing this latter possibility, the i m m u n o b l o t of wildtype and me" thymocyte proteins shown in Fig. 2 A was reprobed with a n t i -C D 3 -e antibody, and the comigration of this 2 6 -k D TCIL subunit with one of the proteins appearing hyperphosphorylated in T C R -s t i m u l a t e d me" thymocytes was thereby demonstrated (Fig. 2 B) . Based on this observation, we next assessed the tyrosine phosphorylation status of T C R complexes immunoprecipitated from 0.5% N P -4 0 lysates of unstimulated wild-type and me t h y m ocytes. As indicated by the antiphosphotyrosine i m m u n o b l o t shown in Fig. 3 A (left panel) , augmented tyrosine phosphorylation of several proteins in the size range of C D 3 subunits (26 and 19 kD) was again detected in the me cells (Fig. 3 A) , and the identity of these latter phosphoproteins as C D 3 -e and TC1L-~, respectively, was established by reprobing of the latter filter with a n t i -C D 3 -e antibody, as well as by the demonstration of enhanced phosphorylation of T C R -~ chains immunoprecipitated from me thymocytes (Fig. 3 A) . Together, these data provide strong evidence for the hyperphosphorylation of the TCIL components m P T P l C -d e f i c i e n t thymocytes, and thus identify the T C R subunits as potential substrates for P T P 1 C .
In view of'these observations, the possibility that P T P 1 C physically associates with the TCR. was also explored by a n t i -P T P l C i m m u n o b l o t t i n g analysis of T C R i m m u n o -precipitates from resting and a n t i -T C R antibody-treated EL4 thymoma cells. As shown in Fig. 3 B, P T P I C was easily detectable in the T C R precipitates derived from both resting and stimulated cells, the amount of TCR-associated P T P 1 C appearing essentially unchanged by cell stimulation. Similarly, P T P I C was coprecipitated with the T C R component CD3-e, from both resting and stimulated thymocytes (Fig. 3 B) , and phosphorylated species in the size range of T C R subunits were also detected by antiphosphotyrosine immunoblotting analysis o f a n t i -P T P l C i m m u n oprecipitates derived from wild-type thymocyte lysates (data not shown). Association of the TC1K with P T P t C was also studied by examining interactions of this phosphatase with CD5, a membrane glycoprotein that associates with T C R~ and undergoes rapid tyrosine phosphorylation after T C R ligation consequent to interactions with src-related PTKs (28) (29) (30) . As shown in Fig. 4 , the results of anti phosphotyrosine and anti-PTP1C immunoblotting analysis of CD5 immunoprecipitates from resting and anti-TCR-stimulated thymocytes confirmed that CD5 is rapidly phosphorylated after T C R ligation, and also demonstrated the capacity of P T P 1 C to associate with CD5 in activated thymocytes. In view of the recognized binding of CD5 molecules with the T C R complex, these observations provide further evidence for the physical association of P T P I C with the T C R .
Identification of Vav-and Grb2-associated Phosphoproteins as Substrates for P T P 1 C in Activated Thymocytes.
In addition to interactions with various cell-surface receptors, PTP1C has recently been shown to asssociate with both the 95-kD product of the Vav protooncogene and the Grb2/mSos complex in activated hemopoietic cells (31). While the biochemical function of Vav is uncertain, Vav has been found to have GEF activity for Ikas in T lymphocytes (32) , and has been identified as an essential participant in the cellular response to TC1L stimulation by results showing that genetic ablation of Vav expression severely impedes TCRevoked signal transduction and thymocyte differentiation (33, 34) . Similarly, the Grb2 adaptor appears to be of considerable importance to T cell signaling by virtue of its role in coupling TCR-associated PTKs to the 1Las GEF, mSos, and thus to the activation of Ras (35, 36) . Accordingly, the capacity of PTP1C to associate with Vav and Grb2/mSos suggests that PTP1C influence on TCtL signal transduction is also realized through its effects on downstream biochemical events that are required for activation of the tkas response pathway. To address this issue, the tyrosine phosphorylation of Vav and the association of Vav and Grb2 with other phosphotyrosine-containing proteins were examined in resting and antigen receptor-stimulated thymocytes of me, me ~, and wild-type mice For these studies, lysates from Con A or anti-TCR antibody-treated mutant and control thymocytes were precipitated with anti-Vav or anti-Grb2 antibodies and glutathione-Sepharose-bound GST-Vav SH2 domain or GST-Vav Grb2 SH2 domain fusion proteins, and the precipitated complexes were then subjected to antiphosphotyrosine immunoblotting. As depicted in Figs. 5, A and B, the analysis ofVav immunoprecipitates in these cells showed that Vav is constitutively phosphorylated in both wild-type and mutant thymocytes, but, as has been previously reported, tyrosine phosphorylation of this protein increased rapidly after TCR ligation (23). This analysis also revealed the presence of several other phosphoproteins of'~70-75 kD and of 38 kD, in the Vav immunoprecipitates from stimulated mutant and wildtype cells. However, in contrast to Vav, for which the levels and kinetics of tyrosine phosphorylation were comparable in the wild-type and mutant thymocytes, tyrosine phosphorylation of these latter Vav-associated phosphoproteins appeared, at least within the first 5 rain of receptor stimulation, to be considerably more pronounced in me and to a lesser extent, me" thymocytes, relative to control thymocytes. This result cannot be ascribed to differences in the amount of Vav protein among the various samples, since reprobing of these immunoblots revealed the amount of Vav to be equivalent in all lanes (data not shown). Since increased and sustained tyrosine phosphorylation of proteins in this same approximate size range was also detected in whole-cell lysates from anti-TC1K-stimulated me" thymocytes (Fig. 2) , it appears likely that PTP1C modulates the tyrosine phosphorylation of these proteins and may thereby influence their association with Vav after TC1L ligation. Conversely, while our previous data have revealed the association of Vav with both PTP1C protein and phosphatase activity (31), the current findings suggest that PTP1C does not modulate TCR-induced Vav tyrosine phosphorylation, and thus imply that any effects PTP1C exerts on the function of Vav in relation to T cell signal relay reflect the actions of this phosphatase on Vav-associated proteins and/or signaling effectors proximal to Vav activafon.
Previous results from our group and others have demonstrated the capacity of both PTP1C and Vav to associate with the Grb2 adaptor protein, a molecule which by virtue of its SH2 and SH3 domains binds to both tyrosine phosphorylated receptor or receptor-associated adaptor proteins and to the mSos GEF, respectively, and thereby plays a key role in linking receptor to Ras activation in many cell types (36, 37) . In view of these data, as well as the apparent influence of PTP1C on phosphoprotein binding to Vav after TCR ligation, the possibility that PTP1C modulation of receptor-triggered activation reflects its effects on tyrosinephosphorylated signaling molecules normally recruited to the Vav and Grb2 SH2 domains was next examined. To this end, lysates from resting and stimulated control and me" thymocytes were incubated with GST-Vav SH2 domain and GST-Grb2 SH2 domain fusion proteins, and the SH2 domain-bound phosphoproteins were then visualized by antiphosphotyrosine immunoblotting analysis. As illustrated in Fig. 5 C, the results of this analysis revealed stinmlated T cell lysates to contain multiple Vav SH2 domain-associated tyrosine phosphoproteins which, based on apparent molecular mass, include some of the same phosphorylated proteins (70-75 and 38 kD) coprecipitated with Vav from activated T cells (Fig. 5, A and B) , as well as additional species of 120 and 26 kD, respectively. These findings are consistent with previous data that indicate association of the Vav SH2 domain with 70-kD and 74-kD phosphoproteins in activated Jurkat cells (38) . Moreover, as the tyrosine phosphorylation of the Vav SH2-associated phosphoprotems detected in the stinmlated thymocytes studied here was again more pronounced and sustained in me" compared to control cells, these results provide further evidence that PTP1C effects on T cell signal transduction involve the modulation of Vav SH2 domain-mediated interactions with phosphorylated signaling effectors, presumably because of PTP1C's capacity to tyrosine dephosphorylate at least some of these phosphoproteins.
Induction of tyrosine phosphoprotein binding to the Grb2 adaptor SH2 domain was also evaluated in anti-TCR-treated me" and wild-type thymocytes, and as shown in Fig. 6 A, this analysis revealed a prominent 38-kD phosphoprotein (herein designated as pp38) to be associated with Grb2 SH2 in both the me" and wild-type stinmlated cells: again, the level and duration of pp38 tyrosine phosphorylation were augmented in me" relative to the control thymocytes. Similarly, a 38-kD phosphoprotein was the predominant molecular species coprecipitated with Grb2 from wild-type thymocytes after TCR ligation (Fig. 6 B) . Since this species was found to comigrate with the Vav SH2 domain-associated 38-kD phosphoprotein and was no longer detectable in Grb2 SH2 domain precipitates derived from activated thymocyte lysates pretreated with an excess of GST-Vav SH2 domain fusion protein (data not shown), it appears likely that this 38-kD Grb2 SH2-binding phosphoprotein represents the same protein associated with the Vav SH2 domain in anti-TClk-stimulated thymocytes. While the identity of pp38 was not established here, a phosphoprotein of a similar molecular mass (i.e., 36-38 kD) has been shown to interact with not only Grb2, but also PLC-~/1 and phosphatidylinositol-3 kinase in activated T cells (39) (40) (41) . Based on these data, pp38 has been implicated in the coupling of TCR-associated PTKs to signaling effectors such as the Grb2/mSos complex, and accordingly to Ras activation (40) , a hypothesis consistent with recent data linking the uncoupling ofpp38 from the Grb2/mSos complex to the attenuation of the Ras activation response in T cells (42) . While it is currently unclear whether the 38-kD species identified here represents Lnk, a recently isolated SH2 domain-containing protein with biochemical properties similar to those of pp38 (43) , the current findings that reveal T C R ligation to induce pp38 association with not only the Grb2 SH2 domain, but also with the SH2 domain ofVav, a putative G D P / G T P exchanger for Ras, are consistent with the contended role for pp38 in the biochemical cascade linking T C R ligation to Ras nucleotide exchange. By extension, these data imply that PTP1C, by virtue of its effects on pp38 associations with both Vav and Grb2, plays a pivotal role in regulating receptor-initiated signaling events immediately upstream to Ras activation.
The enhanced tyrosine phosphorylation of various Vavand Grb2-associated phosphoproteins detected in P T P 1 C - Figure 7 . In vitro tyrosine dephosphorylation of Vav SH2-associated phosphoproteins by GST-PTPIC fusion protein. Lysates prepared from 5 • 107 anti-TCR antibody/avidin-treated wild-type thymocytes were incubated for 1 h with 5 ~g Vav SH2 domain fusion protein adsorbed to glutathione-Sepharose, and the complexes were then retrieved and incubated for the indicated times in phosphatase buffer alone (ctrl) or buffer containing 1 la.g GST-PTP1C fusion protein. In vitro dephosphorylation was assessed by immunoblotting with anti-phosphotyrosine antibody. Arrows indicate positions of three prominent Vav SH2 domain-associated phosphoproteins of N70, 38, and 26 kD, respectively. deficient thymocytes after T C R ligation suggested that these latter proteins represent targets for PTP1C-mediated dephosphorylation. To investigate this possibility, the capacity o f PTP1C to tyrosine dephosphorylate Vav-associated phosphoproteins was examined by incubating G S TVav SH2 domain precipitates from activated T cell lysates with recombinant PTP1C. As shown in Fig. 7 , antiphosphotyrosine immunoblotting analyses of these P T P 1 Ctreated precipitates revealed the progressive dephosphorylation o f pp38, the latter being undetectable at 30 min after enzyme addition, as well as dephosphorylation of a second species of r kD, possibly representing a Vav-associated T C R component. These results do not appear to reflect the random targeting of all tyrosine phosphorylated species in the samples by the recombinant protein, since the phosphorylation state of a third Vav-binding phosphoprotein of 70 kD appeared to be unaffected by PTP1C, at least during the 30-min interval of this analysis. To further address the possibility that the 38-and 26-kD phosphoproteins represent P T P I C substrates, however, lysates prepared from wild-type thymocytes treated with pervanadate, a tyrosine phosphatase inhibitor known to induce intracellular changes that mimick those observed during TCR-triggered T cell activation (14) , were precipitated with either G S T -PTP1C or the catalytically inert G S T -C / S PTP1C fusion proteins, and the effect of abrogating P T P I C activity on the enzyme's association with phosphoproteins in activated thymocytes was then assessed by antiphosphotyrosine immunoblotting. The results of this analysis revealed both versions of the P T P l C -G S T fusion proteins to coprecipirate a number of phosphoproteins from stimulated T cells, but as shown in Fig. 8 , many of these species appeared (19-26 kD) observed in A, 0.5% Triton lysates prepared from 3 • 1(17 pervanadatetreated thymocytes were precipitated with either anti-TCP, antibodies or GST-Vav SH2 domain fusion proteins and aliquots of the GST-Vav SH2 domain complexes were then reprecipitated with anti-TCP,-{ antibody, anti-CD3-e antibody, or lnurine lgG, as described in Materials and Methods. The reprecipitated proteins were resolved over SI)S-PAGE, transferred to mtrocellulose, and immunoblotted with antiphosphotyrosine antibody. Arrows indicate the positions of the TCR-~ (plg) and C1)3-~ (p26) chains. In both panels, positions of molecular inass standards are shown on the left. markedly more phosphorylated in the lysates precipitated with the catalytically inactive instead of the wild-type PTP1C fusion protein. Among these latter phosphoproteins, we detected species o f 38, 26, 21, and 19 kD that comigrated with phosphoproteins precipitated from activated thymocyte lysates by a n t i -T C R antibodies and/or GST-Vav SH2 domain fusion proteins, and that are thus likely to represent the same molecular species found to be aberrantly phosphorylated in TCP-and Vav immunoprecipitates from activated me and me ~ thymocytes. This contention is supported by the results of reprecipitation analyses that were used to determine whether any of the 19-26-kD species precipitated from the activated cells by GST-Vav SH2 domain fusion proteins represented T C R components. As shown in Fig. 8 B, the results of this latter analysis revealed the presence o f both TC1L-~ and CD3-e in Vav SH2 domain precipitates from activated thymocytes. Thus, these data confirm the association of both Vav and PTPI C with T C R components in activated T cells and, based on the reduction in phosphorylation of the 19-26-and 38-kD proteins when precipitated with active vs. catalytically inert G S T -P T P 1 C fusion proteins, these findings support the contention that pp38 and the phosphorylated components o f the T C R complex represent substrates for PTP1C. While these observations might also be explained by indirect effects o f PTP1C on the phosphorylation o f these latter proteins, for example, through the modulation of one or more PTK activities, the capacity o f PTP1C to associate with and tyrosine dephosphorylate in vitro at least some of these species (Fig. 7 ) strongly suggests that these phosphoproteins represent physiologic substrates for PTP1C. Accordingly, the negative regulatory effects of P T P I C on TCP,. signaling capacity appear to be realized through the dephosphorylation of activated T C R components, as well as the downstream signaling effectors that are normally involved in the induction of Ras activation.
TCR-evoked M A P Kinase Aaivation Is Prolonged in PTP1C-
deficient Tkymocytes. In view o f these data implicating PTP1C in the regulation of the signaling cascades linking T C R stimulation to Ras activation, the influence of PTP1C on the Ras regulatory pathway was further examined by evaluating the effects of PTP1C deficiency on T C R -p r oyoked activation of MAP kinase (MAPK). MAPKs belong to a group o f serine/threonine kinases shown in many cell systems to engage in sequential phosphorytation cascades that direct P, as activation signals to the nucleus (44) . With specific respect to antigen receptor signaling in T cells, the induction o f MAPK activity appears tightly coupled to Ras activation, TCR-elicited increases in MAPK activity being essentially abrogated by the loss of Ras function and the genetic disruption of either R.as or MAPK function yielding very similar defects in thymocyte development in vivo (45, 46) . Accordingly, to assess the influence of PTP1C oi1 signaling events downstream to T C R -i n d u c e d IZas activation, antibodies reactive with the ERK2 MAPK were used to immunoprecipitate MAPK from resting and anti-TCR. stimulated me" and wild-type thymocytes, and the immune complexes were then evaluated for their ability to phosphorylate MBP. As shown in Fig. 9 A, the results of this analysis indicate the rapid induction of increased MAPK activity in both the me" and normal cells after T C R crosslinking. However, while the absence of PTP1C activity did not appear to influence basal levels of MAPK activity or the peak kinase activity observed immediately after receptor ligation (Fig. 9, A and B) , the increases in MAPK activity induced by TCP, stimulation were consistently prolonged in the me" relative to the control cells. Thus, while MAPK ac- Kinetics of MAPK activation are altered in PTPlC-deficient motheaten thymocytes. Lysates were prepared from 3 x 10 7 anti-TCR antibody/avidin-or PMA-stimulated C57BL/6J meV/me v (Me") and congenic wild-type (WT) thymocytes at the indicated times after cell stimulation. Lysate proteins were then immunoprecipitated with anti-ERK2 antibody, and the immune complexes then evaluated for their ability to phosphorylate MBP after SDS-PAGE fractionation and autoradiography. tivity fell rapidly to basal levels in the normal thymocytes, levels of this kinase activity remained markedly increased in the me ~ cells, even at 20 min after cell stimulation. By contrast, the magnitude and kinetics of MAPK activation after PMA stimulation were no different in the mutant and control cells (Fig. 9 B) . Thus, the sustained increases in MAPK activity observed in the me v thymocytes after TCR stimulation cannot be ascribed to an intrinsic abnormality in MAPK function per se, but instead appear to reflect the consequence of defects in upstream molecular interactions through which Ras and MAPKs are recruited to the antigen receptor signaling pathway. Irrespective of the mechanisms whereby PTP1C deficiency perturbs the activation of Ras/MAPK, these findings identify PTP1C as a signaling element that is potentially involved in the attenuation of the Ras response to TCR ligation.
Discussion
The data reported in this paper indicate a significant role for PTP1C in regulating the T cell response to antigen receptor stimulation, and they suggest that PTP1C effects on the signaling pathways evoked by TCR engagement are predominantly inhibitory. The data link the negative influence of PTP1C on T cell signaling to this enzyme's interactions with and likely dephosphorylation of the resting and activated TCR complex components, as well as various cytosolic phosphoproteins, most notably pp38, which are recruited to the Vav and Grb2 SH2 domains after TCR engagement. The current findings strongly suggest that these latter phosphoproteins are directly dephosphorylated by PTP1C, but do not preclude the possibility that their phosphorylation state is modulated indirectly by PTP1C through its effects on PTK function, particularly in light of recent data implicating PTP1C in the negative regulation of Lck (19) and ZAP-70 (47) activities. While this latter issue remains to be resolved, the data reported here revealing the association of PTP1C deficiency with enhancement in TCR-induced cellular proliferation, activation of MAPK, and tyrosine phosphorylation of TCR components, as well as Grb2-and Vav-binding phosphoproteins, provide biochemical and functional evidence that PTP1C serves to downregulate the coupling of TCR stimulation to Ras activation and as such exerts a critical influence on the delivery of ligand-binding signals to the nucleus.
At the present time, the structural basis for PTP1C-TCR interaction is unclear, as this association does not appear to be substantially altered by receptor engagement and is therefore unlikely to be mediated through PTP1C SH2 domain binding to TCR phosphotyrosine residues. It is also unclear whether the increase in constitutive tyrosine phosphorylation of putative TCR elements detected in me thymocytes reflects ligand-independent receptor activation consequent to the lack of PTPIC activity, or alternatively, enhanced/prolonged stimulation of the TCR in vivo by ligands in the thymic environment. While these issues remain to be resolved, the data strongly suggest that PTPIC influence on TCR signaling is realized at least in part through the maintenance of the resting TCR in a tyrosinedephosphorylated state, a role for PTP1C also previously proposed in relation to its effects on the BCR (15) .
In addition to PTP1C association with TCR subunits, the current data also demonstrate the capacity of PTP1C to associate with CD5, a transmembrane protein expressed on both thymocytes and T cells and previously identified as a TCR-associated signaling element targeted for PTK-mediated tyrosine phosphorylation in activated T cells (30) . In contrast to TCR-~ and CD3-e, CD5 association with PTP1C was somewhat enhanced in activated thymocytes in the context of CD5 tyrosine phosphorylation and may therefore reflect the interaction of PTP1C SH2 domains with CD5 phosphowrosine residues. While this possibility requires further analysis, the association of PTPIC with CD5 is of particular interest in view of recent data showing thymocyte hyperresponsiveness to TCR stimulation in mice rendered genetically deficient for CD5 expression (48) . Since these latter data suggest that CD5 acts as a negative regulator of the TCR.-mediated signal transduction events governing thymocyte selection, the capacity of PTP1C to associate with and potentially modulate CD5 tyrosine phosphorylation status raises the possibility that PTP 1C inhibitory effects on TCR. signaling are relevant to the regulation of intrathymic selection events. Although this hypothesis requires further investigation, a role for PTP1C in regulating TCR-mediated T cell selection is also implied by the current data suggesting that PTP1C acts to attenuate antigen receptor-triggered Ras/MAPK activation, a biochemical event recently shown to be required for TCR-induced positive selection (45, 46) . Thus, while overt defects in thymocyte maturation were not detected in motheaten mice, the possibility remains that the inappropriate activation of P,.as/MAPK pathways caused by PTP1C deficiency alters TCt< signal circuitry in a manner that shifts the balance of positive and negative selection processes during thymocyte ontogeny. In other words, the effects of PTP1C deficiency on P, as activity may be associated with aberrant maturation of autoreactive thymocytes that are normally subject to intrathymic deletion. It is currently unknown whether the coupling of TCP,-induced Ras activation to selection involves the upstream activation of CDS, but the suggested role for PTP1C in regulating TCR-driven thymocyte selection is consistent with the severe autoimmune syndrome expressed in motheaten mice and with previous data revealing an influence of this phosphatase on the signaling events coupling BCR engagement not only to cell proliferation/activation, but also to programmed cell death (16, 49) . In addition, in view of the well-recognized link between aberrant tkas activation and malignant transformation, PTP1C effects on Ras may also be relevant to the transformation of lymphoid cells, a possibility supported by the increased susceptibility of me" and nle heterozygotes to lymphoproliferative disease (50) .
Although the current data identify. TCR components as well as pp38 and other Vav-and Grb2-binding phosphoproteins as likely substrates for PTP1C activity in activated thymocytes, the structural interactions that underlie these observations remain unclear. However, when considered in relation to previous data showing the capacity of PTP1C to interact with both Vav and Grb2 (31), as well as the current data demonstrating the binding of the Vav SH2 domain with phosphorylated components of the TCFZ, these findings are consistent with cumulative data in the literature linking intracellular signal transduction to the assembly ofmultimeric complexes within which various effectors interact so as to further propagate the activation signal. The likely juxtaposition of PTPIC, Grb2, and phosphorylated subunits of the TCR within this multimeric unit raises the possibility that PTP1C functions in this network in not only a regulatory capacity, i.e., through tyrosine dephosphorylation of other complex components, but also i,1 an adaptor fashion, i.e., by providing a link between phosphorylated TCR. subunits and the Grb2 SH2 domain. The posit of an adaptor role for PTP1C provides a molecular explanation for the mode of Grb2 recruitment into the signaling pathway originating from the TCR, and is also consistent with previous data revealing the structurally similar Syp tyrosine phosphatase to act as a linker for coupling-activated growth factor receptors to Grb2 (5 i). While a similar role is also subserved by the SH2 domain-containing Shc protein in relation to a number of growth factor receptors (52), Shc does not appear to play a predominant role in linking Grb2 to the activated TCR, since we (data not shown) and others (37) have not detected substantial levels of phosphorylated Shc in Grb2 or Grb2 SH2 domain precipitates from activated T cells. By contrast, in conjunction with published data showing Vav and Grb2 association to be mediated through dimerization of their respective SH3 domains (53), the current demonstration ofVav SH2 domain-mediated interaction with the phosphorylated TCP,. in activated thymocytes suggests that Vav function in T cell signaling may involve the coupling of Grb2 to the activated receptor components. In this context, the reported effects of Vav on Ras activity may derive from Vav-mediated enhancement of Grb2/mSos association rather than through Vav-induced GDP/GTP exchange on Ras, a possibility previously invoked to explain the discrepancy between Vav structural properties and putative biologic activity (53) . In any case, irrespective of the extent to which Vav and/or PTP1C act as adaptors in relation to TCR signal relay, the data presented here suggest that the contributions of PTP1C and the signaling effectors with which it associates to the propagation of TCP,.-derived activation signals are likely to reflect the capacity of these molecules to participate in divm~e combinations of molecular interactions and to thereby assume more than one function in relation to signal relay. Accordingly, the further exploitation of PTPlC-deficient mice toward the dissection of PTP1C functions in relation to the signaling transducing molecules with which it associates represents a promising avenue towards delineating the molecular mechanisms for translating TCR stimulation into a multiplicity of physiologic outcomes.
